VRPX

Virpax Pharmaceuticals, Inc. Common Stock

Delisted

VRPX was delisted on the 3rd of April, 2025.

7 hedge funds and large institutions have $1.12M invested in Virpax Pharmaceuticals, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

Holders
7
Holders Change
+2
Holders Change %
+40%
% of All Funds
0.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
SM
1
Sabby Management
Florida
$704K 154,737 -45,263 -23%
ZCA
2
Zeke Capital Advisors
Pennsylvania
$205K 45,000
VF
3
Virtu Financial
New York
$107K 23,625 +23,625 New
SC
4
Saltoro Capital
Texas
$80K 17,615 -9,385 -35%
UBS Group
5
UBS Group
Switzerland
$18K 3,942 +962 +32%
Morgan Stanley
6
Morgan Stanley
New York
$3K 716 +716 New
Osaic Holdings
7
Osaic Holdings
Arizona
-89 Closed
CFGS
8
Concourse Financial Group Securities
Alabama
Wells Fargo
9
Wells Fargo
California
$0 11 +11 New